Bayer agrees to pay $7.25bn to settle Roundup weedkiller cancer lawsuits
Briefly

Bayer agrees to pay $7.25bn to settle Roundup weedkiller cancer lawsuits
"The agrochemical maker Bayer and attorneys for cancer patients announced a proposed $7.25bn settlement on Tuesday to resolve thousands of US lawsuits alleging the company failed to warn people that its popular weedkiller Roundup could cause cancer. The proposed settlement comes as the US supreme court is preparing to hear arguments on Bayer's assertion that the Environmental Protection Agency's approval of Roundup without a cancer warning should invalidate claims filed in state courts. That case would not be affected by the proposed settlement."
"Germany-based Bayer, which acquired the Roundup maker Monsanto in 2018, disputes the assertion that the weedkiller's key ingredient, glyphosate, can cause non-Hodgkin lymphoma. But the company has warned that mounting legal costs are threatening its ability to continue selling the product in US agricultural markets. Litigation uncertainty has plagued the company for years, and this settlement gives the company a road to closure, Bayer's CEO, Bill Anderson, said on Tuesday."
Bayer and attorneys for cancer patients proposed a $7.25bn settlement to resolve thousands of US lawsuits alleging failure to warn that Roundup could cause cancer. The settlement was filed in St Louis circuit court in Missouri and still requires court approval. The move comes while the US supreme court prepares to hear Bayer's claim that EPA approval of Roundup without a cancer warning should bar state-court claims; that case would not be affected by the settlement. Bayer disputes that glyphosate causes non-Hodgkin lymphoma but says mounting legal costs threaten its ability to sell Roundup in US agricultural markets.
Read at www.theguardian.com
Unable to calculate read time
[
|
]